Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease with a great diversity of clinical manifestations which is difficult to manage. IVIGs represent promising immunoregulatory agents with the ability to control SLE without subsequent predisposition to infectious complications. Despite the implied risk of developing renal failure due to IVIG, considerable beneficial effects on lupus nephritis are reported. In this review, the clinical and adverse effects, and machanism of action, with special emphasis on modulation, of idiotypic network is discussed.
Zandman-Goddard G , Shoenfeld Y . Novel approches to therapy for SLE . Eur J Int Med2000; 11: 130–134 .
2.
Krause I , Blank M , Kopolovic J et al. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin . J Rheumatol1995; 22: 1068–1074 .
3.
Sugisaki T , Shiwachi S , Yonekura M . High dose intravenous gamaglobulin for membraneous nephropathy, membranoproliferative glomerulonephritis and lupus nephritis . Fed Proc1982; 41: 692-692 .
4.
Lin CY , Hsu HC , Chiang H . Improvement of histological and immunological change in steroid and immunosuppressive drugresistant lupus nephritis by high-dose intravenous gamma globulin . Nephron1989; 53: 303–310 .
5.
Francioni C , Galeazzi M , Fioravanti A et al. Long-term i.v. Ig treatment in systemic lupus erythematosus . Clin Exp Rheumatol1994; 12: 163–168 .
6.
Levy Y , Sherer Y , Ahmed A et al. A study of 20 SLE patients with intravenous immunoglobulin-clinical and serological response . Lupus1999; 8: 1-8 .
7.
Oliet A , Hernandez E , Gallar P , Vigil A . High-dose intravenous gamma-globulin in systemic lupus erythematosus [letter] . Nephron1992; 62: 465-465 .
8.
Winder A , Molad Y , Ostfeld I et al. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases . J Rheumatol1993; 20: 495–498 .
9.
Akashi K , Nagasawa K , Mayumi T et al. Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins . J Rheumatol1990; 17: 375–379 .
10.
Levy Y , Sherer Y , George J et al. Intravenous immunoglobulin treatment of lupus nephritis . Semin Arthritis Rheum2000; 29: 321–327 .
11.
Becker BN , Fuchs H , Hakim R . Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease . J Am Soc Nephrol1995; 5: 1746–1750 .
12.
Lin CY , Racis SP . In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration . Int Arch Allergy Appl Immunol1986; 79: 286–290 .
13.
Tomino Y , Sakai H , Takaya M et al. Solubilization of intraglomerular deposits of IgG immune complexis by human sera or gamma-globulin in patients with lupus nephritis . Clin Exp Immunol1984; 58: 42–48 .
14.
Boletis JN , Ioannidis JP , Boki KA , Moutsopoulos HM . Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis . Lancet1999; 354: 569–570 .
15.
De Vita S , Ferraccioli GF , Di Poi E et al. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience . Clin Exp Rheumatol1996; 14: S85–S92 .
16.
Barton JC , Herrera GA , Galla JH et al. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin . Am J Med1987; 82: 624–629 .
17.
Stahl M , Schifferli JA . The renal risks of high-dose intravenous immunoglobulin treatment . Nephrol Dial Transplant1998; 13: 2182-2185 .
18.
Renal insufficiency and failure associated with immune globulin intravenous therapy <Eth> United States, 1985–1998 . MMWR Morb Mortal Wkly Rep1999; 48: 518–521 .
19.
Cantu TG , Hoehn-Saric EW , Burgess KM et al. Acute renal failure associated with immunoglobulin therapy . Am J Kidney Dis1995; 25: 228–234 .
20.
Ahsan N , Palmer BF , Wheeler D et al. Intravenous immunoglobulininduced osmotic nephrosis . Arch Intern Med1994; 154: 1985–1987 .
21.
Dalakas MC . Intravenous immune globuline therapy for neurologic diseases . Ann Intern Med1997; 126: 721–730 .
22.
Elkayam O , Paran D , Milo R et al. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases . Ann Rheum Dis2000; 59: 77-77 .
23.
Kessary-Shoham H , Levy Y , Shoenfeld Y et al. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration . J Autoimmun1999; 13: 129–135 .
24.
Lawn N , Wijdicks EF , Burritt MF . Intravenous immune globulin and pseudohyponatremia [letter] . New Engl J Med1998; 27: 632-632 .
25.
Rauova L , Rovensky J , Shoenfeld Y . High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus . Isr Med Assoc J2000; 2: 388–392 .
26.
Dwyer JM . Manipulating the immune system with immune globulin . New Engl J Med1992; 326: 107–115 .
27.
Silvestris F , D'Amore O , Cafforio P et al. Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG . Clin Exp Immunol1996; 104: 91–97 .
28.
Roldan R , Roman J , Lopez D et al. Treatment of hemolytic anemia and severe thrombocytopenia with high-dose methylprednisolone and intravenous immunoglobulins in SLE . Scand J Rheumatol1994; 23: 218–219 .
29.
Aharon A , Levy Y , Bar-Dayan Y et al. Successful treatment of early secondary myelofibrosis in SLE with IVIG . Lupus1997; 6: 408–411 .
30.
Linardaki GD , Boki KA , Fertakis A , Tzioufas AG . Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin . Scand J Rheumatol1999; 28: 189–191 .
31.
Lafferty TE , Smith JB , Schuster SJ , DeHoratius RJ . Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus . Arthritis Rheum1997; 40: 775–778 .
32.
Sherer Y , Langevitz P , Levy Y et al. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin . Lupus1999; 8: 324–327 .
33.
Hjortkjoer Petersen H , Nielsen H et al. High dose immunoglobulin therapy in pericarditis caused by SLE [letter] . Scand J Rheumatol1990; 19: 91–93 .
34.
Disla E , Rhim HR , Reddy A et al. Reversible cardiogenic shock in a patient with lupus myocarditis [letter] . J Rheumatol1993; 20: 2174-2174 .
35.
Sherer Y , Levy Y , Langevitz P et al. Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin . Clin Rheumatol1999; 18: 170–173 .
36.
Tomer Y , Shoenfeld Y . Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin . Clin Exp Rheumatol1992; 10: 391–393 .
37.
Lesprit P , Mouloud F , Bierling P et al. Prolonged remission of SLE associated polyradiculoneuropathy after a single course of intravenous immunoglobulin . Scand J Rheumatol1996; 25: 177–179 .
38.
Somerset DA , Raine-Fenning N , Gordon C et al. Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus . Eur J Obstet Gynecol Reprod Biol1998; 79: 227–229 .
